BC
VRDN icon

Brookfield Corp’s Viridian Therapeutics VRDN Stock Holding History

Brookfield Corp’s Portfolio VRDN Stock Details VRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-27,915
Closed -$815K – 769
2022
Q4 		$815K Buy
+27,915
New +$815K ﹤0.01% 503